60 results on '"Rojas Velasco G."'
Search Results
2. Chest compressions as a rescue manoeuvre to maintain aortic valve opening during left ventricular distention syndrome on venoarterial ECMO
- Author
-
Manzur-Sandoval, D., primary, Salazar-Delgado, J.O., additional, Jiménez-Rodríguez, G.M., additional, and Rojas-Velasco, G., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Compresiones torácicas como maniobra de rescate para mantener la apertura de la válvula aórtica durante el síndrome de distensión ventricular izquierdo en la oxigenación por membrana extracorpórea venoarterial
- Author
-
Manzur-Sandoval, D., primary, Salazar-Delgado, J.O., additional, Jiménez-Rodríguez, G.M., additional, and Rojas-Velasco, G., additional
- Published
- 2024
- Full Text
- View/download PDF
4. Role of beta-3 adrenergic receptor polymorphism TRY64ARG in heart failure
- Author
-
Jimenez Rodriguez, G, primary, Elizalde-Silva, J L, additional, Manzur-Sandoval, D, additional, Cota-Apodaca, L, additional, Ramos-Enriquez, A, additional, Bucio-Reta, E, additional, Lazcano-Diaz, E, additional, Baeza-Herrera, L, additional, Santos-Martinez, L, additional, Gonzalez-Ruiz, F, additional, Gaytan-Garcia, C, additional, Hernandez-Gonzalez, G L, additional, and Rojas-Velasco, G, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- Author
-
Marconi, V, Ramanan, A, de Bono, S, Kartman, C, Krishnan, V, Liao, R, Piruzeli, M, Goldman, J, Alatorre-Alexander, J, de Cassia Pellegrini, R, Estrada, V, Som, M, Cardoso, A, Chakladar, S, Crowe, B, Reis, P, Zhang, X, Adams, D, Ely, E, Ahn, M, Akasbi, M, Altclas, J, Ariel, F, Ariza, H, Atkar, C, Bertetti, A, Bhattacharya, M, Briones, M, Budhraja, A, Burza, A, Camacho Ortiz, A, Caricchio, R, Casas, M, Cevoli Recio, V, Choi, W, Cohen, E, Comulada-Rivera, A, Cook, P, Cornejo Juarez, D, Daniel, C, Degrecci Relvas, L, Dominguez Cherit, J, Ellerin, T, Enikeev, D, Erico Tanni Minamoto, S, Fiss, E, Furuichi, M, Giovanni Luz, K, Gonzalez, O, Gordeev, I, Gruenewald, T, Hamamoto Sato, V, Heo, E, Heo, J, Hermida, M, Hirai, Y, Hutchinson, D, Iastrebner, C, Ioachimescu, O, Jain, M, Juliani Souza Lima, M, Khan, A, Kremer, A, Lawrie, T, Macelwee, M, Madhani-Lovely, F, Malhotra, V, Martinez Resendez, M, Mckinnell, J, Milligan, P, Minelli, C, Moran Rodriguez, M, Parody, M, Paulin, P, Pellegrini, R, Pemu, P, Procopio Carvalho, A, Puoti, M, Purow, J, Ramesh, M, Rea Neto, A, Robinson, P, Rodrigues, C, Rojas Velasco, G, Saraiva, J, Scheinberg, M, Schreiber, S, Scublinsky, D, Sevciovic Grumach, A, Shawa, I, Simon Campos, J, Sofat, N, Spinner, C, Sprinz, E, Stienecker, R, Suarez, J, Tachikawa, N, Tahir, H, Tiffany, B, Vishnevsky, A, Westheimer Cavalcante, A, Zirpe, K, Marconi V. C., Ramanan A. V., de Bono S., Kartman C. E., Krishnan V., Liao R., Piruzeli M. L. B., Goldman J. D., Alatorre-Alexander J., de Cassia Pellegrini R., Estrada V., Som M., Cardoso A., Chakladar S., Crowe B., Reis P., Zhang X., Adams D. H., Ely E. W., Ahn M. -Y., Akasbi M., Altclas J. D., Ariel F., Ariza H. A., Atkar C., Bertetti A., Bhattacharya M., Briones M. L., Budhraja A., Burza A., Camacho Ortiz A., Caricchio R., Casas M., Cevoli Recio V., Choi W. S., Cohen E., Comulada-Rivera A., Cook P., Cornejo Juarez D. P., Daniel C., Degrecci Relvas L. F., Dominguez Cherit J. G., Ellerin T., Enikeev D., Erico Tanni Minamoto S., Fiss E., Furuichi M., Giovanni Luz K., Gonzalez O., Gordeev I., Gruenewald T., Hamamoto Sato V. A., Heo E. Y., Heo J. Y., Hermida M., Hirai Y., Hutchinson D., Iastrebner C., Ioachimescu O., Jain M., Juliani Souza Lima M. P., Khan A., Kremer A. E., Lawrie T., MacElwee M., Madhani-Lovely F., Malhotra V., Martinez Resendez M. F., McKinnell J., Milligan P., Minelli C., Moran Rodriguez M. A., Parody M. L., Paulin P., Pellegrini R. D. C., Pemu P., Procopio Carvalho A. C., Puoti M., Purow J., Ramesh M., Rea Neto A., Robinson P., Rodrigues C., Rojas Velasco G., Saraiva J. F. K., Scheinberg M., Schreiber S., Scublinsky D., Sevciovic Grumach A., Shawa I., Simon Campos J., Sofat N., Spinner C. D., Sprinz E., Stienecker R., Suarez J., Tachikawa N., Tahir H., Tiffany B., Vishnevsky A., Westheimer Cavalcante A., Zirpe K., Marconi, V, Ramanan, A, de Bono, S, Kartman, C, Krishnan, V, Liao, R, Piruzeli, M, Goldman, J, Alatorre-Alexander, J, de Cassia Pellegrini, R, Estrada, V, Som, M, Cardoso, A, Chakladar, S, Crowe, B, Reis, P, Zhang, X, Adams, D, Ely, E, Ahn, M, Akasbi, M, Altclas, J, Ariel, F, Ariza, H, Atkar, C, Bertetti, A, Bhattacharya, M, Briones, M, Budhraja, A, Burza, A, Camacho Ortiz, A, Caricchio, R, Casas, M, Cevoli Recio, V, Choi, W, Cohen, E, Comulada-Rivera, A, Cook, P, Cornejo Juarez, D, Daniel, C, Degrecci Relvas, L, Dominguez Cherit, J, Ellerin, T, Enikeev, D, Erico Tanni Minamoto, S, Fiss, E, Furuichi, M, Giovanni Luz, K, Gonzalez, O, Gordeev, I, Gruenewald, T, Hamamoto Sato, V, Heo, E, Heo, J, Hermida, M, Hirai, Y, Hutchinson, D, Iastrebner, C, Ioachimescu, O, Jain, M, Juliani Souza Lima, M, Khan, A, Kremer, A, Lawrie, T, Macelwee, M, Madhani-Lovely, F, Malhotra, V, Martinez Resendez, M, Mckinnell, J, Milligan, P, Minelli, C, Moran Rodriguez, M, Parody, M, Paulin, P, Pellegrini, R, Pemu, P, Procopio Carvalho, A, Puoti, M, Purow, J, Ramesh, M, Rea Neto, A, Robinson, P, Rodrigues, C, Rojas Velasco, G, Saraiva, J, Scheinberg, M, Schreiber, S, Scublinsky, D, Sevciovic Grumach, A, Shawa, I, Simon Campos, J, Sofat, N, Spinner, C, Sprinz, E, Stienecker, R, Suarez, J, Tachikawa, N, Tahir, H, Tiffany, B, Vishnevsky, A, Westheimer Cavalcante, A, Zirpe, K, Marconi V. C., Ramanan A. V., de Bono S., Kartman C. E., Krishnan V., Liao R., Piruzeli M. L. B., Goldman J. D., Alatorre-Alexander J., de Cassia Pellegrini R., Estrada V., Som M., Cardoso A., Chakladar S., Crowe B., Reis P., Zhang X., Adams D. H., Ely E. W., Ahn M. -Y., Akasbi M., Altclas J. D., Ariel F., Ariza H. A., Atkar C., Bertetti A., Bhattacharya M., Briones M. L., Budhraja A., Burza A., Camacho Ortiz A., Caricchio R., Casas M., Cevoli Recio V., Choi W. S., Cohen E., Comulada-Rivera A., Cook P., Cornejo Juarez D. P., Daniel C., Degrecci Relvas L. F., Dominguez Cherit J. G., Ellerin T., Enikeev D., Erico Tanni Minamoto S., Fiss E., Furuichi M., Giovanni Luz K., Gonzalez O., Gordeev I., Gruenewald T., Hamamoto Sato V. A., Heo E. Y., Heo J. Y., Hermida M., Hirai Y., Hutchinson D., Iastrebner C., Ioachimescu O., Jain M., Juliani Souza Lima M. P., Khan A., Kremer A. E., Lawrie T., MacElwee M., Madhani-Lovely F., Malhotra V., Martinez Resendez M. F., McKinnell J., Milligan P., Minelli C., Moran Rodriguez M. A., Parody M. L., Paulin P., Pellegrini R. D. C., Pemu P., Procopio Carvalho A. C., Puoti M., Purow J., Ramesh M., Rea Neto A., Robinson P., Rodrigues C., Rojas Velasco G., Saraiva J. F. K., Scheinberg M., Schreiber S., Scublinsky D., Sevciovic Grumach A., Shawa I., Simon Campos J., Sofat N., Spinner C. D., Sprinz E., Stienecker R., Suarez J., Tachikawa N., Tahir H., Tiffany B., Vishnevsky A., Westheimer Cavalcante A., and Zirpe K.
- Abstract
Background: Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory properties. This study evaluates the efficacy and safety of baricitinib in combination with standard of care for the treatment of hospitalised adults with COVID-19. Methods: In this phase 3, double-blind, randomised, placebo-controlled trial, participants were enrolled from 101 centres across 12 countries in Asia, Europe, North America, and South America. Hospitalised adults with COVID-19 receiving standard of care were randomly assigned (1:1) to receive once-daily baricitinib (4 mg) or matched placebo for up to 14 days. Standard of care included systemic corticosteroids, such as dexamethasone, and antivirals, including remdesivir. The composite primary endpoint was the proportion who progressed to high-flow oxygen, non-invasive ventilation, invasive mechanical ventilation, or death by day 28, assessed in the intention-to-treat population. All-cause mortality by day 28 was a key secondary endpoint, and all-cause mortality by day 60 was an exploratory endpoint; both were assessed in the intention-to-treat population. Safety analyses were done in the safety population defined as all randomly allocated participants who received at least one dose of study drug and who were not lost to follow-up before the first post-baseline visit. This study is registered with ClinicalTrials.gov, NCT04421027. Findings: Between June 11, 2020, and Jan 15, 2021, 1525 participants were randomly assigned to the baricitinib group (n=764) or the placebo group (n=761). 1204 (79·3%) of 1518 participants with available data were receiving systemic corticosteroids at baseline, of whom 1099 (91·3%) were on dexamethasone; 287 (18·9%) participants were receiving remdesivir. Overall, 27·8% of participants receiving baricitinib and 30·5% receiving placebo progressed to meet the primary endpoint (odds ratio 0·85 [95% CI 0·67 to 1·08], p=0·18), with an absolute risk difference of −2·7 percentage points (
- Published
- 2021
6. Low calf circumference is associated with hospital length of stay in patients with chronic heart failure: a retrospective analysis
- Author
-
Cruz-Sánchez, J.J., Aguilar-Rodríguez, C.G., Acosta-Osuna, M.G., Tovar-Hernández, M.D.L.L., Rojas-Velasco, G., Osuna-Padilla, I.A., and Arias-Mendoza, A.
- Published
- 2024
- Full Text
- View/download PDF
7. Características clínicas e implicación pronóstica de la fibrilación auricular en el período postoperatorio de cirugía cardíaca con circulación extracorpórea
- Author
-
Salinas-Ulloa, C.Y., Gopar-Nieto, R., García-Cruz, E., Rojas-Velasco, G., and Manzur-Sandoval, D.
- Abstract
[Display omitted]
- Published
- 2024
- Full Text
- View/download PDF
8. [Paraneoplastic limbic encephalitis: a difficult-to-diagnose condition]
- Author
-
Ramos-Rivas M, Rojas-Velasco G, Rocio Acuna Hidalgo, Oa, Márquez-Valero, Rh, Arellano-Bernal, and Castro-Martínez E
- Subjects
Antigens, Neoplasm ,Limbic Encephalitis ,Neoplasms ,Humans ,Autoimmunity ,Syndrome ,Antibodies - Abstract
Paraneoplastic syndromes can be defined as manifestations in distant places of tumors or metastasis, which are not related with tumoral growth. Most of these syndromes are caused by substances secreted by the tumor, that mimic natural hormones, or interfere with plasma proteins.The rate of paraneoplastic syndromes with neurological manifestations is less than 0.5/100,000 per year, and affect about 0.01% of cancer patients. The pathogenesis of neurological paraneoplastic syndromes is attributed to humoral autoimmunity, due to the existence of a great variety of antibodies in relationship with the neurological alterations associated. Nevertheless, the absence of antibodies does not exclude a neurological paraneoplastic syndromes, just as antibodies may be found without a neurological paraneoplastic syndrome. The characteristic symptoms of paraneoplastic limbic encephalitis are confusion of acute onset, mood changes, hallucinations, loss of short term memory, and seizures; these symptoms generally develop in days or weeks, but may present suddenly. Image studies, cerebral spinal fluid evaluation, and serologic tests are the most useful in diagnosing a neurological paraneoplastic syndrome. The treatment requires two different approaches. The first one is through the suppression of the immune response generated by neurological damage. The second, is by removing the tumor as the source of the antigen. The latter is often the only effective treatment.The paraneoplastic limbic encephalitis is an unusual and hard to diagnose entity, which can easily be confused with psychiatric problems. An early diagnosis and treatment is very important to avoid nonreversible neuronal damage.
- Published
- 2009
9. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- Author
-
Vincent C Marconi, Athimalaipet V Ramanan, Stephanie de Bono, Cynthia E Kartman, Venkatesh Krishnan, Ran Liao, Maria Lucia B Piruzeli, Jason D Goldman, Jorge Alatorre-Alexander, Rita de Cassia Pellegrini, Vicente Estrada, Mousumi Som, Anabela Cardoso, Sujatro Chakladar, Brenda Crowe, Paulo Reis, Xin Zhang, David H Adams, E Wesley Ely, Mi-Young Ahn, Miriam Akasbi, Javier David Altclas, Federico Ariel, Horacio Alberto Ariza, Chandrasekhar Atkar, Anselmo Bertetti, Meenakshi Bhattacharya, Maria Luisa Briones, Akshay Budhraja, Aaliya Burza, Adrian Camacho Ortiz, Roberto Caricchio, Marcelo Casas, Valeria Cevoli Recio, Won Suk Choi, Emilia Cohen, Angel Comulada-Rivera, Paul Cook, Dora Patricia Cornejo Juarez, Carnevali Daniel, Luiz Fernando Degrecci Relvas, Jose Guillermo Dominguez Cherit, Todd Ellerin, Dmitry Enikeev, Suzana Erico Tanni Minamoto, Elie Fiss, Motohiko Furuichi, Kleber Giovanni Luz, Jason D. Goldman, Omar Gonzalez, Ivan Gordeev, Thomas Gruenewald, Victor Augusto Hamamoto Sato, Eun Young Heo, Jung Yeon Heo, Maria Hermida, Yuji Hirai, David Hutchinson, Claudio Iastrebner, Octavian Ioachimescu, Manish Jain, Maria Patelli Juliani Souza Lima, Akram Khan, Andreas E. Kremer, Thomas Lawrie, Mark MacElwee, Farah Madhani-Lovely, Vinay Malhotra, Michel Fernando Martínez Resendez, James McKinnell, Patrick Milligan, Cesar Minelli, Miguel Angel Moran Rodriguez, Maria Leonor Parody, Priscila Paulin, Priscilla Pemu, Ana Carolina Procopio Carvalho, Massimo Puoti, Joshua Purow, Mayur Ramesh, Alvaro Rea Neto, Philip Robinson, Cristhieni Rodrigues, Gustavo Rojas Velasco, Jose Francisco Kerr Saraiva, Morton Scheinberg, Stefan Schreiber, Dario Scublinsky, Anete Sevciovic Grumach, Imad Shawa, Jesus Simon Campos, Nidhi Sofat, Christoph D. Spinner, Eduardo Sprinz, Roger Stienecker, Jose Suarez, Natsuo Tachikawa, Hasan Tahir, Brian Tiffany, Alexander Vishnevsky, Adilson Westheimer Cavalcante, Kapil Zirpe, Marconi, V, Ramanan, A, de Bono, S, Kartman, C, Krishnan, V, Liao, R, Piruzeli, M, Goldman, J, Alatorre-Alexander, J, de Cassia Pellegrini, R, Estrada, V, Som, M, Cardoso, A, Chakladar, S, Crowe, B, Reis, P, Zhang, X, Adams, D, Ely, E, Ahn, M, Akasbi, M, Altclas, J, Ariel, F, Ariza, H, Atkar, C, Bertetti, A, Bhattacharya, M, Briones, M, Budhraja, A, Burza, A, Camacho Ortiz, A, Caricchio, R, Casas, M, Cevoli Recio, V, Choi, W, Cohen, E, Comulada-Rivera, A, Cook, P, Cornejo Juarez, D, Daniel, C, Degrecci Relvas, L, Dominguez Cherit, J, Ellerin, T, Enikeev, D, Erico Tanni Minamoto, S, Fiss, E, Furuichi, M, Giovanni Luz, K, Gonzalez, O, Gordeev, I, Gruenewald, T, Hamamoto Sato, V, Heo, E, Heo, J, Hermida, M, Hirai, Y, Hutchinson, D, Iastrebner, C, Ioachimescu, O, Jain, M, Juliani Souza Lima, M, Khan, A, Kremer, A, Lawrie, T, Macelwee, M, Madhani-Lovely, F, Malhotra, V, Martinez Resendez, M, Mckinnell, J, Milligan, P, Minelli, C, Moran Rodriguez, M, Parody, M, Paulin, P, Pellegrini, R, Pemu, P, Procopio Carvalho, A, Puoti, M, Purow, J, Ramesh, M, Rea Neto, A, Robinson, P, Rodrigues, C, Rojas Velasco, G, Saraiva, J, Scheinberg, M, Schreiber, S, Scublinsky, D, Sevciovic Grumach, A, Shawa, I, Simon Campos, J, Sofat, N, Spinner, C, Sprinz, E, Stienecker, R, Suarez, J, Tachikawa, N, Tahir, H, Tiffany, B, Vishnevsky, A, Westheimer Cavalcante, A, and Zirpe, K
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,medicine.medical_specialty ,Asia ,medicine.medical_treatment ,Population ,Placebo ,Antiviral Agents ,Corrections ,Dexamethasone ,Baricitinib ,Double-Blind Method ,Adrenal Cortex Hormones ,Internal medicine ,Clinical endpoint ,medicine ,Humans ,education ,Adverse effect ,Mechanical ventilation ,education.field_of_study ,Sulfonamides ,Alanine ,business.industry ,SARS-CoV-2 ,Hazard ratio ,Absolute risk reduction ,COVID-19 ,Odds ratio ,Articles ,South America ,Adenosine Monophosphate ,COVID-19 Drug Treatment ,Europe ,Treatment Outcome ,Purines ,North America ,Azetidines ,Pyrazoles ,business - Abstract
Summary Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory properties. This study evaluates the efficacy and safety of baricitinib in combination with standard of care for the treatment of hospitalised adults with COVID-19. Methods In this phase 3, double-blind, randomised, placebo-controlled trial, participants were enrolled from 101 centres across 12 countries in Asia, Europe, North America, and South America. Hospitalised adults with COVID-19 receiving standard of care were randomly assigned (1:1) to receive once-daily baricitinib (4 mg) or matched placebo for up to 14 days. Standard of care included systemic corticosteroids, such as dexamethasone, and antivirals, including remdesivir. The composite primary endpoint was the proportion who progressed to high-flow oxygen, non-invasive ventilation, invasive mechanical ventilation, or death by day 28, assessed in the intention-to-treat population. All-cause mortality by day 28 was a key secondary endpoint, and all-cause mortality by day 60 was an exploratory endpoint; both were assessed in the intention-to-treat population. Safety analyses were done in the safety population defined as all randomly allocated participants who received at least one dose of study drug and who were not lost to follow-up before the first post-baseline visit. This study is registered with ClinicalTrials.gov , NCT04421027 . Findings Between June 11, 2020, and Jan 15, 2021, 1525 participants were randomly assigned to the baricitinib group (n=764) or the placebo group (n=761). 1204 (79·3%) of 1518 participants with available data were receiving systemic corticosteroids at baseline, of whom 1099 (91·3%) were on dexamethasone; 287 (18·9%) participants were receiving remdesivir. Overall, 27·8% of participants receiving baricitinib and 30·5% receiving placebo progressed to meet the primary endpoint (odds ratio 0·85 [95% CI 0·67 to 1·08], p=0·18), with an absolute risk difference of −2·7 percentage points (95% CI −7·3 to 1·9). The 28-day all-cause mortality was 8% (n=62) for baricitinib and 13% (n=100) for placebo (hazard ratio [HR] 0·57 [95% CI 0·41–0·78]; nominal p=0·0018), a 38·2% relative reduction in mortality; one additional death was prevented per 20 baricitinib-treated participants. The 60-day all-cause mortality was 10% (n=79) for baricitinib and 15% (n=116) for placebo (HR 0·62 [95% CI 0·47–0·83]; p=0·0050). The frequencies of serious adverse events (110 [15%] of 750 in the baricitinib group vs 135 [18%] of 752 in the placebo group), serious infections (64 [9%] vs 74 [10%]), and venous thromboembolic events (20 [3%] vs 19 [3%]) were similar between the two groups. Interpretation Although there was no significant reduction in the frequency of disease progression overall, treatment with baricitinib in addition to standard of care (including dexamethasone) had a similar safety profile to that of standard of care alone, and was associated with reduced mortality in hospitalised adults with COVID-19. Funding Eli Lilly and Company. Translations For the French, Japanese, Portuguese, Russian and Spanish translations of the abstract see Supplementary Materials section.
- Published
- 2021
10. Comment on the firsts insights of the arterial hypertension study in México (RIHTA): are we doing things right?
- Author
-
Aguilar-López R, Rojas-Velasco G, and Toledo-Elías R
- Subjects
- Humans, Child, Adolescent, Female, Child, Preschool, Infant, Male, Infant, Newborn, Retrospective Studies, Reoperation statistics & numerical data, Cardiac Surgical Procedures methods, Follow-Up Studies, Tricuspid Valve Insufficiency surgery, Ebstein Anomaly surgery, Hospitals, Pediatric
- Published
- 2024
- Full Text
- View/download PDF
11. Circulatory support with triple cannulation V-PaA ECMO in a patient with acute right ventricular failure and refractory hypoxemia secondary to diffuse alveolar hemorrhage: A case report.
- Author
-
Encarnación-Martínez U, Torres-Pulido A, Lazcano-Díaz EA, Manzur-Sandoval D, Baeza-Herrera LA, González-Ruiz FJ, Jiménez-Rodríguez GM, and Rojas-Velasco G
- Abstract
A 48-year-old woman presented to the emergency department with a one-week history of progressive dyspnea. During her hospitalization, the diagnosis of diffuse alveolar hemorrhage was made. She subsequently developed respiratory failure and acute right ventricular failure. Despite medical treatment, she continued to experience distributive shock due to a generalized inflammatory response. Circulatory support with ECMO was needed. We opted for triple cannulation to manage the multiorgan failure as a bridge to recovery. We describe our experience with an uncommon cannulation technique: veno-pulmonary-arterial cannulation, which enabled us to address cardiogenic shock, refractory hypoxemia, and distributive shock, leading to the successful recovery of the patient., Competing Interests: The authors declare they have no known competing financial interest or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
12. ELANE rs17223045C/T and rs3761007G/A variants: Protective factors against COVID-19.
- Author
-
Fragoso JM, Vargas-Alarcón G, Martínez-Flores ÁE, Montufar-Robles I, Barbosa-Cobos RE, Rojas-Velasco G, and Ramírez-Bello J
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Angiotensin-Converting Enzyme 2 genetics, Angiotensin-Converting Enzyme 2 metabolism, Case-Control Studies, Protective Factors, SARS-CoV-2, COVID-19 genetics, Leukocyte Elastase genetics, Polymorphism, Single Nucleotide
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for causing coronavirus disease 2019 (COVID-19). The development and severity of this infectious disease is influenced by a combination of environmental and genetic factors. Angiotensin-converting enzyme 2 (ACE2) facilitates SARS-CoV-2 entry into human cells, with transmembrane serine protease 2 (TMPRSS2) playing a crucial role in S protein priming. Other proteases, such as cathepsin L and elastase, neutrophil-expressed (ELANE), have the capability to prime the S protein and contribute to SARS-CoV-2 infection. ELANE variants have not been previously examined in COVID-19 patients. We aimed to assess the association of single nucleotide variants (SNVs) within ELANE with COVID-19 and biochemical markers. The study included 319 SARS-CoV-2-infected patients and 288 controls. Genotyping of ELANE rs17216663C/T (Pro257Leu), rs17223045C/T (As1n30Asn), and rs3761007G/A was conducted using a 5'-nuclease allelic discrimination assay (TaqMan assay). Our findings indicate that ELANE rs17223045C/T (C vs T: odds ratio [OR] 0.08, P = 0.005, and CC vs CT: OR 0.08, P = 0.005) and rs3761007G/A (G vs A: OR 0.38, P = 0.009, and GG vs GA: OR 0.40, P = 0.008) confer protection against COVID-19. However, these variants were not associated with biochemical markers. In conclusion, our data suggests that ELANE rs17223045C/T and rs3761007G/A SNVs may play a protective role against COVID-19.
- Published
- 2024
- Full Text
- View/download PDF
13. [Circulatory support with venovenous ECMO in a patient with reperfusion pulmonary edema after pulmonary artery thromboendarterectomy].
- Author
-
Lazcano-Díaz EA, Encarnación-Martínez U, Gaytán-García CJ, Manzur-Sandoval D, González-Ruiz FJ, García-Cruz E, Ramos-Enríquez Á, Santos-Martínez LE, Cota-Apodaca LA, Hernández-Mejía BI, Escamilla-Ríos DE, and Rojas-Velasco G
- Subjects
- Humans, Female, Middle Aged, Hypertension, Pulmonary etiology, Pulmonary Artery surgery, Extracorporeal Membrane Oxygenation methods, Endarterectomy methods, Pulmonary Edema etiology, Pulmonary Embolism etiology, Postoperative Complications etiology
- Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension characterized by the obstruction of pulmonary arteries secondary to chronic thromboembolism. Pulmonary thromboendarterectomy surgery (PTE) is the main treatment for patients with CTEPH, as it removes the chronic thrombi from the pulmonary arteries. Pulmonary reperfusion syndrome is a common complication of the surgery, which involves the development of pulmonary edema in the area where blood perfusion improves after the surgery. The incidence of this syndrome varies from 8 to 91% depending on the criteria used for diagnosis, and it is one of the most serious complications of pulmonary thromboendarterectomy. In such cases, circulatory support with extracorporeal membrane oxygenation (ECMO) has become a valuable therapeutic modality. We present the case of a 60-year-old woman with a history of acute pulmonary embolism due to deep vein thrombosis of the right pelvic limb who was diagnosed later with CTEPH who was admitted for scheduled surgical treatment involving bilateral PTE. However, during the immediate postoperative period, she developed cardiogenic shock and refractory hypoxemia secondary to pulmonary reperfusion syndrome following the surgical procedure. As a result, she required veno-venous ECMO circulatory support for 6 days, leading to resolution of the pulmonary condition and clinical improvement.
- Published
- 2024
- Full Text
- View/download PDF
14. Assessing the venous system: Correlation of mean systemic filling pressure with the venous excess ultrasound grading system in cardiac surgery.
- Author
-
Utrilla-Alvarez JD, Gopar-Nieto R, García-Cruz E, Lazcano-Díaz E, Jiménez-Rodrìguez GM, Rojas-Velasco G, and Manzur-Sandoval D
- Subjects
- Humans, Cross-Sectional Studies, Hyperemia, Cardiac Surgical Procedures, Cardiovascular System
- Abstract
Background: Evaluation of the venous system has long been underestimated as an important component of the circulatory system. As systemic venous pressure increases, the perfusion pressure to the tissues is compromised. During initial resuscitation in cardiac surgery, excessive fluid administration is associated with increased morbidity and mortality., Methods: We conducted a cross-sectional study of 60 consecutive adult patients who underwent cardiac surgery and in whom it was possible to obtain the venous excess ultrasound (VExUS) grading system and mean systemic filling pressure (Pmsf) in the postoperative period upon admission, at 24 and 48 h. We then determined the correlation between VExUS grading and Pmsf., Results: On admission, patients with VExUS grading 0 predominated, with a progressive increase in venous congestion and an increase in Pmsf over the course of the first 48 h. There was a strong positive correlation between VExUS grading and the invasive measurement of Pmsf at 24 and 48 h after arrival. The presence of grade 2 or grade 3 venous congestion in the postoperative period poses an increased risk of developing acute kidney injury., Conclusion: The VExUS grading system indicates a high degree of systemic venous congestion in the first 48 h of the postoperative period after cardiac surgery and correlates with the Pmsf, which is the best surrogate of stressed circulatory volume., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
15. Percutaneous balloon atrial septostomy for left heart decompression post-repair of partial anomalous pulmonary venous drainage and aortic valve replacement.
- Author
-
Hurtado Belizario KSA, Jimenez Rodriguez GM, García Cruz E, García Montes JA, Falcón Quispe LA, León Blanchet MF, Reyes Ortega A, Espinosa González P, and Rojas Velasco G
- Abstract
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2023
- Full Text
- View/download PDF
16. [North-south syndrome, a complication of circulatory assistance with Veno-Arterial ECMO. A case report.]
- Author
-
Lazcano-Diaz EA, Hurtado Belizario KSA, Riveros-Nina D, Pérez-Manjarrez A, Manzur-Sandoval D, Baeza-Herrera L, and Rojas-Velasco G
- Abstract
We present the case of a 34-year-old male patient with a history of Marfan syndrome who was admitted to the emergency room for acute aortic regurgitation secondary to aneurysmal dilation of the ascending thoracic aorta. In the postoperative period, post-cardiotomy cardiogenic shock was documented, so circulatory support was initiated with peripheral Veno-Arterial ECMO, which developed hypoxemia due to bacterial pneumonia and data compatible with North-South syndrome. We present a review, non-conventional cannulation strategies and a diagnostic alternative for this entity., Competing Interests: Conflicto de intereses: Los autores declaran que no tener conflicto de intereses
- Published
- 2023
- Full Text
- View/download PDF
17. Dissociation Between Measures of Macrocirculation and Microcirculation in Patients Undergoing Cardiac Surgical Procedure.
- Author
-
Manzur-Sandoval D, Gopar-Nieto R, Torres-Pulido A, Pérez-Manjarrez AA, Hurtado-Belizario KSA, Riveros-Nina DG, Quirazco-Córdova RE, Utrilla-Álvarez JD, Elizalde-Silva JL, Rojas-Velasco G, and Ospina-Tascón GA
- Abstract
Background: In the postoperative period of cardiac surgical procedure, there is an imbalance in the ratio of oxygen supply to oxygen consumption that leads to organic dysfunction and death. There is evidence of microcirculation involvement in cardiac surgical procedure, and a dysregulated inflammatory response similar to sepsis can occur., Methods: We present a cohort of 280 consecutive adults who were monitored in the postoperative period after cardiac surgical procedure. We performed serial measurements of macrocirculatory indices, indices of global oxygenation, CO
2 -derived indices, and perfusion indices in the first 24 hours postoperatively., Results: We identified a dissociation between circulatory macrohemodynamic parameters/global oxygenation indices and the CO2 -derived indices. The CO2 -derived indices constitute a surrogate for microcirculatory flow and indicate the presence of anaerobic metabolism., Conclusions: A better understanding of these clinical variables will help establish optimal management protocols. It will also aid in the identification of patients in subpopulations with organic dysfunction despite conventional circulatory parameters within normal limits who can be overlooked if this exhaustive hemodynamic evaluation is not performed., (© 2023 The Authors.)- Published
- 2023
- Full Text
- View/download PDF
18. Left atrial veno-arterial extracorporeal membrane oxygenation in post-myocardial infarction ventricular septal defect with cardiogenic shock: a case report.
- Author
-
Jiménez-Rodríguez GM, Rojas-Velasco G, Arias-Sánchez EA, Manzur-Sandoval D, Vega-Servin NS, Quirazco-Cordova RE, and Eid-Lidt G
- Abstract
Background: Ventricular septal defect (VSD) complicating acute myocardial infarction (MI) represents a life-threatening condition and has a mortality of >90% if left untreated., Case Summary: A 53-year-old man with a prior medical history of diabetes and hypertension presented with cardiogenic shock secondary to VSD as a mechanical complication of non-reperfused inferior MI., Discussion: The choice of mechanical support can be difficult in this type of patient. Given the risk of an increased shunt because of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and the increase in left ventricle (LV) afterload, several measures were taken to plan the best ECMO configuration. Given the absence of any real improvement in the LV and an elevated residual ratio between pulmonary and systemic flow (Qp/Qs), the final decision was to switch to left atrial VA-ECMO (LAVA-ECMO). The use of LAVA-ECMO improved the patient's haemodynamics and allowed his condition to stabilize; LAVA-ECMO is feasible and may be effective as a mechanical circulatory support (MCS) strategy for patients in cardiogenic shock due to VSD as a mechanical complication of acute MI., Competing Interests: Conflict of interest: None declared., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
19. Usefulness of the velocity-time integral of the left ventricular outflow tract variability index to predict fluid responsiveness in patients undergoing cardiac surgery.
- Author
-
Pérez-Manjarrez A, García-Cruz E, Gopar-Nieto R, Jiménez-Rodríguez GM, Lazcano-Díaz E, Rojas-Velasco G, and Manzur-Sandoval D
- Abstract
Background: Haemodynamic monitoring of patients after cardiac surgery using echocardiographic evaluation of fluid responsiveness is both challenging and increasingly popular. We evaluated fluid responsiveness in the first hours after surgery by determining the variability of the velocity-time integral of the left ventricular outflow tract (VTI-LVOT)., Methods: We conducted a cross-sectional study of 50 consecutive adult patients who underwent cardiac surgery and in whom it was possible to obtain VTI-LVOT measurements. We then determined the variability and correlations with our pulse pressure variation (PPV) measurements to predict fluid responsiveness., Results: A strong positive correlation was seen between the VTI-LVOT variability index absolute values and PPV for predicting fluid responsiveness in the first hours after cardiac surgery. We also found that the VTI-LVOT variability index has high specificity and a high positive likelihood ratio compared with the gold standard using a cut-off point of ≥ 12%., Conclusions: The VTI-LVOT variability index is a valuable tool for determining fluid responsiveness during the first 6 postoperative hours in patients undergoing cardiac surgery., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
20. A contrast echocardiography-based protocol to rule out thrombus in Venous-Arterial ECMO: A proof of concept.
- Author
-
Baeza-Herrera LA, Hernández-Reyes JP, Lazcano-Díaz EA, Orihuela-Sandoval C, González-Ruiz FJ, Manzur-Sandoval D, Ramos-Enríquez Á, Terrazas-Cervantes E, and Rojas-Velasco G
- Subjects
- Humans, Echocardiography, Extracorporeal Membrane Oxygenation adverse effects, Extracorporeal Membrane Oxygenation methods, Thrombosis etiology
- Abstract
Using an ultrasound-enhancing agent (UEA) has several indications, especially in diagnosing left ventricular thrombus. Herein, we present three cases of patients who were candidates for venous-arterial extracorporeal membrane oxygenation, among whom thrombus was ruled out via contrast echocardiography. The use of a UEA in these patients was a novel approach., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
21. Left circumflex artery injury occurring during mitral valve surgery treated successfully with percutaneous intervention in a high surgical and bleeding risk patient.
- Author
-
Jiménez-Rodríguez GM, Jackson-Pedroza C, Hurtado-Belizario KS, Carmona-Levario P, Encarnación-Martínez U, Carrillo-Vega J, Rojas-Velasco G, and Eid-Lidt G
- Abstract
Perioperative myocardial infarction is a complication of cardiac surgery, and the cause can be multifactorial. Injury of the left circumflex coronary artery has been described, particularly after mitral valve replacement. We present the case of a 72-year-old woman who underwent mitral valve replacement but developed a lesion in the proximal circumflex coronary artery related to partial mechanical kinking caused by a suture. The therapeutic options are surgical or percutaneous. In this patient, the percutaneous strategy was successful., Learning Objective: • Percutaneous coronary intervention is an option in cases involving kinking of the left circumflex coronary artery after mitral valve replacement.• If unable to cross the lesion with a workhorse guide wire, one alternative is to use wires with good support properties and avoid very high tip loads to reduce the risk of perforation.In patients at high risk of bleeding, use of a drug-eluting stent and short-duration dual antiplatelet therapy is recommended., Competing Interests: The authors declare that there is no conflict of interest., (© 2023 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
22. Lactococcus garvieae, an unusual etiology of prosthetic valve endocarditis. First case reported in Mexico.
- Author
-
Rojas-Velasco G, Méndez-Hernández DP, Escobar-Sibaja LE, Cruz-Rodríguez C, Arteaga-Cárdenas G, and Virgen-Cuevas MM
- Subjects
- Lactococcus, Humans, Mexico, Endocarditis, Endocarditis, Bacterial etiology, Heart Valve Prosthesis adverse effects
- Published
- 2023
- Full Text
- View/download PDF
23. Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure.
- Author
-
Montalvo-Ocotoxtle IG, Rojas-Velasco G, Rodríguez-Morales O, Arce-Fonseca M, Baeza-Herrera LA, Arzate-Ramírez A, Meléndez-Ramírez G, Manzur-Sandoval D, Lara-Romero ML, Reyes-Ortega A, Espinosa-González P, and Palacios-Rosas E
- Abstract
Chagas cardiomyopathy (CC), caused by the protozoan Trypanosoma cruzi , is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 200,000 deaths by 2025. The World Health Organization (WHO) considers Chagas disease (CD) as a Neglected Tropical Disease (NTD), which must be acknowledged and detected in time, as it remains a clinical and diagnostic challenge in both endemic and non-endemic regions and at different levels of care. The literature on CC was analyzed by searching different databases (Medline, Cochrane Central, EMBASE, PubMed, Google Scholar, EBSCO) from 1968 until October 2022. Multicenter and bioinformatics trials, systematic and bibliographic reviews, international guidelines, and clinical cases were included. The reference lists of the included papers were checked. No linguistic restrictions or study designs were applied. This review is intended to address the current incidence and prevalence of CD and to identify the main pathogenic mechanisms, clinical presentation, and diagnosis of CC.
- Published
- 2022
- Full Text
- View/download PDF
24. Percutaneous Left Ventricular Unloading in Cardiogenic Shock During Venoarterial Extracorporeal Membrane Oxygenation: A Radial Approach.
- Author
-
Jiménez-Rodríguez GM, Manzur-Sandoval D, Quirazco-Córdova RE, Jiménez-Ruán LA, and Rojas-Velasco G
- Published
- 2022
- Full Text
- View/download PDF
25. Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19.
- Author
-
Posadas-Sánchez R, Fragoso JM, Sánchez-Muñoz F, Rojas-Velasco G, Ramírez-Bello J, López-Reyes A, Martínez-Gómez LE, Sierra-Fernández C, Rodríguez-Reyna T, Regino-Zamarripa NE, Ramírez-Martínez G, Zuñiga-Ramos J, and Vargas-Alarcón G
- Subjects
- Angiotensin-Converting Enzyme 2 genetics, Exonucleases, Humans, Lactic Acid, Oxidoreductases, Peptidyl-Dipeptidase A genetics, SARS-CoV-2 genetics, Serine Endopeptidases genetics, COVID-19 genetics
- Abstract
SARS-CoV-2 uses the ACE2 receptor and the cellular protease TMPRSS2 for entry into target cells. The present study aimed to establish if the TMPRSS2 polymorphisms are associated with COVID-19 disease. The study included 609 patients with COVID-19 confirmed by RT-PCR test and 291 individuals negative for the SARS-CoV-2 infection confirmed by RT-PCR test and without antibodies anti-SARS-CoV-2. Four TMPRSS2 polymorphisms (rs12329760, rs2298659, rs456298, and rs462574) were determined using the 5'exonuclease TaqMan assays. Under different inheritance models, the rs2298659 ( p
codominant2 = 0.018, precessive = 0.006, padditive = 0.019), rs456298 ( pcodominant1 = 0.014, pcodominant2 = 0.004; pdominant = 0.009, precessive = 0.004, padditive = 0.0009), and rs462574 ( pcodominant1 = 0.017, pcodominant2 = 0.004, pdominant = 0.041, precessive = 0.002, padditive = 0.003) polymorphisms were associated with high risk of developing COVID-19. Two risks ( ATGC and GAAC ) and two protectives ( GAGC and GAGT ) haplotypes were detected. High levels of lactic acid dehydrogenase (LDH) were observed in patients with the rs462574 AA and rs456298 TT genotypes ( p = 0.005 and p = 0.020, respectively), whereas, high heart rate was present in patients with the rs462574 AA genotype ( p = 0.028). Our data suggest that the rs2298659, rs456298, and rs462574 polymorphisms independently and as haplotypes are associated with the risk of COVID-19. The rs456298 and rs462574 genotypes are related to high levels of LDH and heart rate.- Published
- 2022
- Full Text
- View/download PDF
26. Correlation between transhepatic and subcostal inferior vena cava ultrasonographic images for evaluating fluid responsiveness after cardiac surgery.
- Author
-
Manzur-Sandoval D, Arteaga-Cárdenas G, Gopar-Nieto R, Lazcano-Díaz E, and Rojas-Velasco G
- Subjects
- Adult, Cross-Sectional Studies, Echocardiography methods, Humans, Cardiac Surgical Procedures methods, Vena Cava, Inferior diagnostic imaging
- Abstract
Background: Echocardiographic monitoring during the postoperative period following cardiac surgery is essential because patients often develop hemodynamic instability from hypovolemia and other causes. Therefore, predicting fluid responsiveness by measuring respirophasic variation in the inferior vena cava (IVC) is essential in this population. Yet it is not always possible to evaluate using the traditional subcostal view., Methods: This cross-sectional study of 36 consecutive adult patients who underwent cardiac surgery included those in whom it was possible to adequately visualize the IVC in both the subcostal and transhepatic views. The maximum and minimum diameters and respirophasic variation were measured in each view. These views were then correlated and the capacity of the transhepatic view to predict fluid responsiveness was evaluated., Results: There was a strong positive correlation between IVC maximum and minimum diameters and respirophasic variation according to subcostal and transhepatic views. Evaluation of IVC respirophasic variation indices using the transhepatic view also showed high sensitivity for predicting fluid responsiveness., Conclusion: There is a correlation between the transhepatic and subcostal views for determining maximum and minimum IVC diameters, and distensibility and variability indices for predicting fluid responsiveness in postoperative cardiac surgery patients., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
27. Aortic Perforation and Ascending Dissection Due to Intra-Aortic Balloon Counterpulsation Implantation in Cardiac Surgery.
- Author
-
González-Ruiz FJ, Rojas-Velasco G, Lazcano-Diaz EA, Manzur-Sandoval D, Baeza-Herrera LA, Cota-Apodaca LA, Bucio-Reta ER, Ramos-Enriquez A, García-Flores CF, and Eid-Lidt G
- Abstract
The intra-aortic balloon pump continues to be a useful ventricular assist device in cardiac surgery. Complications are estimated to be 7% to 40%, significantly high to catastrophic. We describe an aortic injury associated with the use of the device and an interdisciplinary management for the diagnostic and therapeutic approach. ( Level of Difficulty: Intermediate. )., Competing Interests: The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
28. Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients.
- Author
-
Martínez-Gómez LE, Ibarra-González I, Fernández-Lainez C, Tusie T, Moreno-Macías H, Martinez-Armenta C, Jimenez-Gutierrez GE, Vázquez-Cárdenas P, Vidal-Vázquez P, Ramírez-Hinojosa JP, Rodríguez-Zulueta AP, Vargas-Alarcón G, Rojas-Velasco G, Sánchez-Muñoz F, Posadas-Sanchez R, Martínez-Ruiz FJ, Zayago-Angeles DM, Moreno ML, Barajas-Galicia E, Lopez-Cisneros G, Gonzalez-Fernández NC, Ortega-Peña S, Herrera-López B, Olea-Torres J, Juárez-Arias M, Rosas-Vásquez M, Cabrera-Nieto SA, Magaña JJ, Camacho-Rea MDC, Suarez-Ahedo C, Coronado-Zarco I, Valdespino-Vázquez MY, Martínez-Nava GA, Pineda C, Vela-Amieva M, and López-Reyes A
- Subjects
- Humans, SARS-CoV-2, Cross-Sectional Studies, Amino Acids, Phenylalanine, COVID-19, Diabetes Mellitus, Type 2
- Abstract
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection triggers inflammatory clinical stages that affect the outcome of patients with coronavirus disease 2019 (COVID-19). Disease severity may be associated with a metabolic imbalance related to amino acids, lipids, and energy-generating pathways. The aim of this study was to characterize the profile of amino acids and acylcarnitines in COVID-19 patients. A multicenter, cross-sectional study was carried out. A total of 453 individuals were classified by disease severity. Levels of 11 amino acids, 31 acylcarnitines, and succinylacetone in serum samples were analyzed by electrospray ionization-triple quadrupole tandem mass spectrometry. Different clusters were observed in partial least squares discriminant analysis, with phenylalanine, alanine, citrulline, proline, and succinylacetone providing the major contribution to the variability in each cluster (variable importance in the projection >1.5). In logistic models adjusted by age, sex, type 2 diabetes mellitus, hypertension, and nutritional status, phenylalanine was associated with critical outcomes (odds ratio=5.3 (95% CI 3.16-9.2) in the severe vs. critical model, with an area under the curve of 0.84 (95% CI 0.77-0.90). In conclusion the metabolic imbalance in COVID-19 patients might affect disease progression. This work shows an association of phenylalanine with critical outcomes in COVID-19 patients, highlighting phenylalanine as a potential metabolic biomarker of disease severity., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Martínez-Gómez, Ibarra-González, Fernández-Lainez, Tusie, Moreno-Macías, Martinez-Armenta, Jimenez-Gutierrez, Vázquez-Cárdenas, Vidal-Vázquez, Ramírez-Hinojosa, Rodríguez-Zulueta, Vargas-Alarcón, Rojas-Velasco, Sánchez-Muñoz, Posadas-Sanchez, Martínez-Ruiz, Zayago-Angeles, Moreno, Barajas-Galicia, Lopez-Cisneros, Gonzalez-Fernández, Ortega-Peña, Herrera-López, Olea-Torres, Juárez-Arias, Rosas-Vásquez, Cabrera-Nieto, Magaña, Camacho-Rea, Suarez-Ahedo, Coronado-Zarco, Valdespino-Vázquez, Martínez-Nava, Pineda, Vela-Amieva, López-Reyes and Mex-Gen-COVID Initiative Group.)
- Published
- 2022
- Full Text
- View/download PDF
29. Pulmonary artery cannulation during venovenous extracorporeal membrane oxygenation: An alternative to manage refractory hypoxemia and right ventricular dysfunction.
- Author
-
Rojas-Velasco G, Carmona-Levario P, Manzur-Sandoval D, Lazcano-Díaz E, and Damas-de Los Santos F
- Abstract
Venovenous extracorporeal membrane oxygenation (ECMO) has become a rescue therapy for acute respiratory distress syndrome (ARDS) secondary to COVID-19 for patients who are refractory to conventional therapy. However, this therapy comes with complications, and alternative cannulation strategies are needed to overcome these difficulties. In this article, we present a case of venovenous ECMO presenting with refractory hypoxemia and right ventricular dysfunction, which were corrected by cannulating the pulmonary artery. This situation is rarely reported in literature and may constitute an alternative for managing these patients., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
30. Acute Mitral Regurgitation Due to Chordae Tendineae Rupture: A Rare Presentation of Cardiac Amyloidosis.
- Author
-
Aguilar-López R, Sánchez-Rodríguez CC, Manzur-Sandoval D, Flores Calvo M, Aranda-Fraustro A, Jordán-Ríos A, Francisco-Cruz A, and Rojas-Velasco G
- Subjects
- Acute Disease, Adult, Chordae Tendineae diagnostic imaging, Chordae Tendineae pathology, Humans, Male, Mitral Valve pathology, Mitral Valve surgery, Young Adult, Amyloid Neuropathies, Familial complications, Heart Rupture complications, Heart Rupture surgery, Mitral Valve Insufficiency etiology, Mitral Valve Insufficiency surgery
- Abstract
BACKGROUND In cardiac amyloidosis (CA), misfolded proteins deposit in the extracellular space of cardiac tissue. These deposits classically cause restrictive cardiomyopathy with diastolic dysfunction. Although there are at least 30 proteins known to cause amyloid aggregates, 2 main types make up most diagnosed cases: light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR). Since CA is considered a rare condition, it is often underdiagnosed or recognized in the advanced stages. Once amyloid deposits involve the heart tissue, they are associated with a worse outcome and higher mortality rates, especially in patients presenting symptoms of heart failure. CASE REPORT We report a case of a 22-year-old man presenting with acute severe mitral regurgitation, secondary to posterior mitral leaflet chordae tendineae rupture (CTR). Surgical mitral valve replacement with a mechanical prosthesis was performed, and cardiac tissue biopsy samples were obtained. After surgery, the patient improved significantly but suddenly presented with hemodynamic deterioration, until he died due to severe hemodynamic compromise and multiorgan failure. Although the etiology of the CTR was not established before surgical intervention, the histopathological analysis suggested CA. CONCLUSIONS CA diagnosis can be complex, especially in a 22-year-old-man with atypical clinical and imaging manifestations. In this patient, other differential diagnoses were considered, since CA presenting in a young patient is a rare phenomenon and acute mitral regurgitation secondary to CTR presents more frequently in other heart conditions. Furthermore, rapid postoperative deterioration resulted in the patient's death before biopsy samples were available because suspicion of amyloidosis had not been raised until that point.
- Published
- 2022
- Full Text
- View/download PDF
31. The rs8176740 T/A and rs512770 T/C Genetic Variants of the ABO Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets.
- Author
-
Vargas-Alarcón G, Ramírez-Bello J, Posadas-Sánchez R, Rojas-Velasco G, López-Reyes A, Martínez-Gómez L, Ortega-Peña S, Montúfar-Robles I, Barbosa-Cobos RE, Arellano-González M, and Fragoso JM
- Subjects
- Blood Platelets, Case-Control Studies, Humans, Polymorphism, Single Nucleotide, ABO Blood-Group System genetics, ABO Blood-Group System metabolism, COVID-19 genetics, Galactosyltransferases genetics, Galactosyltransferases metabolism, Genetic Predisposition to Disease
- Abstract
We conducted a case-control study in order to evaluate whether ABO gene polymorphisms were associated with a high risk of developing COVID-19 in a cohort of patients. Six ABO gene polymorphisms (rs651007 T / C , rs579459 T / C , rs495828 T/G , rs8176746 A/C , rs8176740 T/A , and rs512770 T / C ) were determined using TaqMan genotyping assays in a group of 415 COVID-19 patients and 288 healthy controls. The distribution of rs651007 T / C , rs579459 T / C , rs495828 T / G , and rs8176746 A / C polymorphisms was similar in patients and healthy controls. Nonetheless, under co-dominant (OR = 1.89, pC
Co-dominant = 6 × 10-6 ), recessive (OR = 1.98, pCRecessive = 1 × 10-4 ), and additive (OR = 1.36, pCAdditive = 3 × 10-3 ) models, the TT genotype of the rs8176740 T/A polymorphism increased the risk of developing COVID-19. In the same way, under co-dominant, recessive, and additive models, the TT genotype of the rs512770 T / C polymorphism was associated with a high risk of developing COVID-19 (OR = 1.87, pCCo-dominant = 2 × 10-3 ; OR = 1.87, pCRecessive = 5 × 10-4 ; and OR = 1.35, pCAdditive = 4 × 10-3 , respectively). On the other hand, the GTC and GAT haplotypes were associated with a high risk of COVID-19 (OR = 5.45, pC = 1 × 10-6 and OR = 6.33, pC = 1 × 10-6 , respectively). In addition, the rs8176740 TT genotype was associated with high-platelet plasma concentrations in patients with COVID-19. Our data suggested that the ABO rs512770 T/C and rs8176740 T/A polymorphisms increased the risk of developing COVID-19 and the plasma concentration of platelets.- Published
- 2022
- Full Text
- View/download PDF
32. ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men.
- Author
-
Martínez-Gómez LE, Herrera-López B, Martinez-Armenta C, Ortega-Peña S, Camacho-Rea MDC, Suarez-Ahedo C, Vázquez-Cárdenas P, Vargas-Alarcón G, Rojas-Velasco G, Fragoso JM, Vidal-Vázquez P, Ramírez-Hinojosa JP, Rodríguez-Sánchez Y, Barrón-Díaz D, Moreno ML, Martínez-Ruiz FJ, Zayago-Angeles DM, Mata-Miranda MM, Vázquez-Zapién GJ, Martínez-Cuazitl A, Barajas-Galicia E, Bustamante-Silva L, Zazueta-Arroyo D, Rodríguez-Pérez JM, Hernández-González O, Coronado-Zarco R, Lucas-Tenorio V, Franco-Cendejas R, López-Jácome LE, Vázquez-Juárez RC, Magaña JJ, Cruz-Ramos M, Granados J, Hernández-Doño S, Delgado-Saldivar D, Ramos-Tavera L, Coronado-Zarco I, Guajardo-Salinas G, Muñoz-Valle JF, Pineda C, Martínez-Nava GA, and López-Reyes A
- Subjects
- Alleles, COVID-19 virology, Diabetes Mellitus, Type 2 genetics, Diabetes Mellitus, Type 2 virology, Genotype, Humans, Male, SARS-CoV-2 pathogenicity, Angiotensin-Converting Enzyme 2 genetics, COVID-19 genetics, Peptidyl-Dipeptidase A genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, affecting more than 219 countries and causing the death of more than 5 million people worldwide. The genetic background represents a factor that predisposes the way the host responds to SARS-CoV-2 infection. In this sense, genetic variants of ACE and ACE2 could explain the observed interindividual variability to COVID-19 outcomes. In order to improve the understanding of how genetic variants of ACE and ACE2 are involved in the severity of COVID-19, we included a total of 481 individuals who showed clinical manifestations of COVID-19 and were diagnosed by reverse transcription PCR (RT-PCR). Genomic DNA was extracted from peripheral blood and saliva samples. ACE insertion/deletion polymorphism was evaluated by the high-resolution melting method; ACE single-nucleotide polymorphism (SNP) (rs4344) and ACE2 SNPs (rs2285666 and rs2074192) were genotyped using TaqMan probes. We assessed the association of ACE and ACE2 polymorphisms with disease severity using logistic regression analysis adjusted by age, sex, hypertension, type 2 diabetes, and obesity. The severity of the illness in our study population was divided as 31% mild, 26% severe, and 43% critical illness; additionally, 18% of individuals died, of whom 54% were male. Our results showed in the codominant model a contribution of ACE2 gene rs2285666 T/T genotype to critical outcome [odds ratio (OR) = 1.83; 95%CI = 1.01-3.29; p = 0.04] and to require oxygen supplementation (OR = 1.76; 95%CI = 1.01-3.04; p = 0.04), in addition to a strong association of the T allele of this variant to develop critical illness in male individuals (OR = 1.81; 95%CI = 1.10-2.98; p = 0.02). We suggest that the T allele of rs2285666 represents a risk factor for severe and critical outcomes of COVID-19, especially for men, regardless of age, hypertension, obesity, and type 2 diabetes., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Martínez-Gómez, Herrera-López, Martinez-Armenta, Ortega-Peña, Camacho-Rea, Suarez-Ahedo, Vázquez-Cárdenas, Vargas-Alarcón, Rojas-Velasco, Fragoso, Vidal-Vázquez, Ramírez-Hinojosa, Rodríguez-Sánchez, Barrón-Díaz, Moreno, Martínez-Ruiz, Zayago-Angeles, Mata-Miranda, Vázquez-Zapién, Martínez-Cuazitl, Barajas-Galicia, Bustamante-Silva, Zazueta-Arroyo, Rodríguez-Pérez, Hernández-González, Coronado-Zarco, Lucas-Tenorio, Franco-Cendejas, López-Jácome, Vázquez-Juárez, Magaña, Cruz-Ramos, Granados, Hernández-Doño, Delgado-Saldivar, Ramos-Tavera, Coronado-Zarco, Guajardo-Salinas, Muñoz-Valle, Pineda, Martínez-Nava and López-Reyes.)
- Published
- 2022
- Full Text
- View/download PDF
33. Focused Transesophageal Echocardiography in Critical Care: The COVID-19 Pandemic.
- Author
-
García-Cruz E, Manzur-Sandoval D, Martínez DS, Gopar-Nieto R, Jordán-Ríos A, Díaz-Méndez A, Lazcano-Díaz E, Rojas-Velasco G, and Baranda-Tovar F
- Abstract
Background: The use of transesophageal echocardiography (TEE) is controversial in patients with COVID-19. The aim of this case series was to demonstrate the usefulness of transesophageal echocardiography in acute cardiovascular care settings in patients with COVID-19 infection., Materials and Methods: We enrolled 13 patients with confirmed SARS-CoV-2 infection admitted to the critical care unit of our center from April 1, 2020, to July 30, 2020, in which transesophageal echocardiography was performed. TOE was performed by three cardiologists with training in echocardiography., Results: The main indication was suspected infective endocarditis in four cases, venovenous extracorporeal membrane oxygenation cannulation in four cases, suspected prosthetic mitral valve dysfunction in two patients, suspected pulmonary embolism in two patients, and acute right ventricular dysfunction and prone position ventilation in one patient. The final diagnosis was confirmed in 11 patients and discarded in 2 patients. None of the operators result infected., Conclusions: TOE is safe in the context of COVID-19 infection; it must be performed in well-selected cases and in a targeted manner., Competing Interests: There are no conflicts of interest., (Copyright: © 2022 Journal of Cardiovascular Echography.)
- Published
- 2022
- Full Text
- View/download PDF
34. Venous-arterial oxygen saturation and serum lactate in the postoperative period of cardiac surgery.
- Author
-
Santos-Martínez LE, Olmos-Temois SG, Ramos-Enríquez Á, González-Escudero EA, Baeza-Herrera LA, López-Polanco MA, Cota-Apodaca LA, González-Ruiz FJ, Melano-Carranza E, and Rojas-Velasco G
- Subjects
- Humans, Female, Cross-Sectional Studies, Oxygen, Lactic Acid, Postoperative Period, Oxygen Saturation, Cardiac Surgical Procedures
- Abstract
Introduction: Oxygen saturation and lactate are markers of tissue hypoxia; they are obtained from central venous and mixed venous sample of the pulmonary artery. The simultaneous behavior of these parameters in the postoperative period of cardiac surgery is unknown., Objective: To characterize the lactate and oxygen saturation of the venous-arterial circuit of the postoperative patient from cardiac surgery., Methods: Design: Analytical cross-sectional. In consecutive patients after cardiac surgery, serum lactate and oxygen saturation of the venous-arterial circuit were obtained. The variables were reported with median (25.75 percentiles). They were analyzed with Kruskal-Wallis ANOVA and respective adjustment, Spearman correlation, the descriptive Bland-Altman statistic and intraclass correlation coefficient (95% confidence interval). A p < 0.05 was considered significant., Results: 244 blood samples from 61 patients were studied. Women 30 (49%). (Oxygen saturation) [lactate] were: arterial 98 (95.3, 99.4%) and 1.7 (1.1, 2.1); peripheral venous 85 (75.4, 94%) and [1.9 (1.35, 2.3)]; central venous 68.8 (58.74, 70.2%) and 1.8 (1.3, 2.3); mixed central venous 66.8 (61.2, 73.1%) and 1.8 (1.3, 2.2), p < 0.05. The best intraclass correlation coefficient for oxygen saturation were from central vein to mixed central vein 0.856 (0.760,0.914); and lactate: 0.954 (0.923, 0.972)., Conclusions: The oxygen saturation differs in the venous-arterial circuit unlike lactate where they are similar. The best values of the intraclass correlation coefficient for lactate and oxygen saturation were those obtained in central vein and mixed central vein., (Copyright: © 2022 Permanyer.)
- Published
- 2022
- Full Text
- View/download PDF
35. Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient.
- Author
-
Anguiano-Álvarez VM, Maza-Larrea JA, Rosado-Hernández FJ, Rojas-Velasco G, and Izaguirre-Ávila R
- Published
- 2021
- Full Text
- View/download PDF
36. Usefulness of Easy-to-Use Risk Scoring Systems Rated in the Emergency Department to Predict Major Adverse Outcomes in Hospitalized COVID-19 Patients.
- Author
-
González-Flores J, García-Ávila C, Springall R, Brianza-Padilla M, Juárez-Vicuña Y, Márquez-Velasco R, Sánchez-Muñoz F, Ballinas-Verdugo MA, Basilio-Gálvez E, Castillo-Salazar M, Cásarez-Alvarado S, Hernández-Diazcouder A, Sánchez-Gloria JL, Sandoval J, González-Pacheco H, Tavera-Alonso C, Rojas-Velasco G, Baranda-Tovar F, and Amezcua-Guerra LM
- Abstract
Background: Several easy-to-use risk scoring systems have been built to identify patients at risk of developing complications associated with COVID-19. However, information about the ability of each score to early predict major adverse outcomes during hospitalization of severe COVID-19 patients is still scarce., Methods: Eight risk scoring systems were rated upon arrival at the Emergency Department, and the occurrence of thrombosis, need for mechanical ventilation, death, and a composite that included all major adverse outcomes were assessed during the hospital stay. The clinical performance of each risk scoring system was evaluated to predict each major outcome. Finally, the diagnostic characteristics of the risk scoring system that showed the best performance for each major outcome were obtained., Results: One hundred and fifty-seven adult patients (55 ± 12 years, 66% men) were assessed at admission to the Emergency Department and included in the study. A total of 96 patients (61%) had at least one major outcome during hospitalization; 32 had thrombosis (20%), 80 required mechanical ventilation (50%), and 52 eventually died (33%). Of all the scores, Obesity and Diabetes (based on a history of comorbid conditions) showed the best performance for predicting mechanical ventilation (area under the ROC curve (AUC), 0.96; positive likelihood ratio (LR+), 23.7), death (AUC, 0.86; LR+, 4.6), and the composite outcome (AUC, 0.89; LR+, 15.6). Meanwhile, the inflammation-based risk scoring system (including leukocyte count, albumin, and C-reactive protein levels) was the best at predicting thrombosis (AUC, 0.63; LR+, 2.0)., Conclusions: Both the Obesity and Diabetes score and the inflammation-based risk scoring system appeared to be efficient enough to be integrated into the evaluation of COVID-19 patients upon arrival at the Emergency Department.
- Published
- 2021
- Full Text
- View/download PDF
37. Right ventricular dysfunction and right ventricular-arterial uncoupling at admission increase the in-hospital mortality in patients with COVID-19 disease.
- Author
-
Manzur-Sandoval D, García-Cruz E, Gopar-Nieto R, Arteaga-Cárdenas G, Rascón-Sabido R, Mendoza-Copa G, Lazcano-Díaz E, Barajas-Campos RL, Jordán-Ríos A, Rodríguez-Jiménez GM, Martínez DS, Murillo-Ochoa AL, Díaz-Méndez A, Bucio-Reta E, Rojas-Velasco G, and Baranda-Tovar F
- Subjects
- Adult, Cross-Sectional Studies, Echocardiography, Doppler, Hospital Mortality, Humans, Pulmonary Artery diagnostic imaging, SARS-CoV-2, Ventricular Function, Right, COVID-19, Ventricular Dysfunction, Right diagnostic imaging
- Abstract
Background: Coronavirus disease 2019 (COVID-19) frequently involves cardiovascular manifestations such as right ventricular (RV) dysfunction and alterations in pulmonary hemodynamics. We evaluated the application of the critical care ultrasonography ORACLE protocol to identify the most frequent alterations and their influence on adverse outcomes, especially those involving the RV (dilatation and dysfunction)., Methods: This cross-sectional study included 204 adult patients with confirmed COVID-19 admitted at three centers. Echocardiography and lung ultrasound images were acquired on admission using the ORACLE ultrasonography algorithm., Results: Two-hundred and four consecutive patients were evaluated: 22 (11.9%) demonstrated a fractional shortening of < 35%; 33 (17.1%) a tricuspid annular plane systolic excursion (TAPSE) of < 17 mm; 26 (13.5%) a tricuspid peak systolic S wave tissue Doppler velocity of < 9.5 cm/sec; 69 (37.5%) a RV basal diameter of > 41 mm; 119 (58.3%) a pulmonary artery systolic pressure (PASP) of > 35 mm Hg; and 14 (11%) a TAPSE/PASP ratio of < .31. The in-hospital mortality rate was 37.6% (n = 71). Multiple logistic regression modeling showed that PASP > 35 mm Hg, RV FS of < 35%, TAPSE < 17 mm, RV S wave < 9.5, and TAPSE/PASP ratio < .31 mm/mm Hg were associated with this outcome. PASP and the TAPSE/PASP ratio had the lowest feasibility of being obtained among the investigators (62.2%)., Conclusion: The presence of RV dysfunction, pulmonary hypertension, and alteration of the RV-arterial coupling conveys an increased risk of in-hospital mortality in patients presenting with COVID-19 upon admission; therefore, searching for these alterations should be routine. These parameters can be obtained quickly and safely with the ORACLE protocol., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
38. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.
- Author
-
Posadas-Sánchez R, Sánchez-Muñoz F, Guzmán-Martín CA, Hernández-Díaz Couder A, Rojas-Velasco G, Fragoso JM, and Vargas-Alarcón G
- Subjects
- Adult, Aged, Angiotensin-Converting Enzyme 2 genetics, Angiotensin-Converting Enzyme 2 metabolism, COVID-19 enzymology, COVID-19 epidemiology, COVID-19 pathology, Dipeptidyl Peptidase 4 metabolism, Female, Gene Frequency, Humans, Male, Mexico epidemiology, Middle Aged, Polymorphism, Single Nucleotide, SARS-CoV-2 isolation & purification, SARS-CoV-2 metabolism, Severity of Illness Index, COVID-19 genetics, Dipeptidyl Peptidase 4 genetics
- Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes de COVID-19 disease use as a principal receptor the angiotensin-converting enzyme-2 (ACE2). It has been suggested that dipeptidyl peptidase-4 (DPP4) can be another possible receptor for this virus. The present study aimed to establish if the DPP4 levels and DPP4 polymorphisms are associated with COVID-19 disease and its severity., Methods: The study included 107 COVID-19 patients and 263 matched-healthy controls. Fifty patients required invasive mechanical ventilation. The DPP4 was quantified in serum using the Bioplex system. Based on the previous results and the functional prediction analysis, we select for the study 5 DPP4 polymorphisms (rs12617336, rs12617656, rs1558957, rs3788979, and rs17574) and these were determined using the 5´exonuclease TaqMan assays., Results: Low levels of DPP4 were observed in COVID-19 patients (46.5 [33.1-57.7] ng/mL) when compared to healthy controls (125.3 [100.3-157.3] ng/mL) (P < 0.0001). Also, patients that required mechanical ventilation showed lower DPP4 levels (42.8 [29.8-56.9] ng/mL) than those that did not need this procedure (49.2 [39.9-65.6] ng/mL) (P = 0.012). DPP4 levels correlated negatively with age, fibrinogen, and platelet levels, and positively with albumin, alanine aminotransferase, and percentage of neutrophils. The DPP4 rs3788979 polymorphism was associated with a high risk of COVID-19 disease and, the TT genotype carriers had the lowest DPP4 levels., Conclusions: In summary, in the present study, an association of low levels of DPP4 with COVID-19 disease and severity was found. The association of the DPP4 rs3788979 polymorphism with COVID-19 is also reported., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
39. Acute right ventricular failure in COVID-19 infection: A case series.
- Author
-
García-Cruz E, Manzur-Sandoval D, Baeza-Herrera LA, Díaz-Méndez A, López-Zamora A, González-Ruiz F, Ramos-Enríquez Á, Melano-Carranza E, Rojas-Velasco G, Álvarez-Álvarez RJ, and Baranda-Tovar FM
- Abstract
Severe forms of COVID-19 infection are associated with the need for invasive mechanical ventilation and thromboembolic complications; those can affect the cardiac function especially the right ventricle performance. Critical care echocardiography has rapidly evolved as the election technique in the evaluation of the critically ill patients. This technique has the advantage that it can be done at patient´s bedside and helps to provide the appropriate treatment and to monitoring maneuver's response. We present 4 patients with a confirmed COVID-19 infection who presented with sudden hemodynamic and / or respiratory deterioration, in which transthoracic echocardiogram showed acute right ventricular failure as the trigger for the event and helped to guide an early therapeutic intervention. < Learning objective: Routine echocardiographic evaluation must be mandatory in patients with COVID-19 infection. The presence of refractory hypoxemia and/or hypotension should raise the suspicion of right ventricle failure and must be evaluated with transthoracic echocardiogram. In the clinical scenario of acute right ventricular failure, rising D-dimer and suspected pulmonary embolism, thrombolysis must be considered even without tomographic confirmation.>., Competing Interests: No conflicts of interest to disclose., (© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
40. Presence of antiphospholipid antibodies in COVID-19: a case series study.
- Author
-
Amezcua-Guerra LM, Rojas-Velasco G, Brianza-Padilla M, Vázquez-Rangel A, Márquez-Velasco R, Baranda-Tovar F, Springall R, Gonzalez-Pacheco H, Juárez-Vicuña Y, Tavera-Alonso C, Sanchez-Muñoz F, and Hernández-Salas M
- Subjects
- Antibodies, Anticardiolipin, Antibodies, Antiphospholipid, Humans, SARS-CoV-2, COVID-19
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2021
- Full Text
- View/download PDF
41. Paradigms about the COVID-19 pandemic: knowledge, attitudes and practices from medical students.
- Author
-
Lincango-Naranjo E, Espinoza-Suarez N, Solis-Pazmino P, Vinueza-Moreano P, Rodriguez-Villafuerte S, Lincango-Naranjo J, Barberis-Barcia G, Ruiz-Sosa C, Rojas-Velasco G, Gravholt D, Golembiewski E, Soto-Becerra P, Khan M, and Ortiz-Prado E
- Subjects
- Adult, Attitude of Health Personnel, COVID-19 diagnosis, COVID-19 therapy, Cross-Sectional Studies, Ecuador epidemiology, Female, Health Care Surveys statistics & numerical data, Humans, Male, Personal Protective Equipment statistics & numerical data, Prognosis, Students, Medical statistics & numerical data, Volunteers statistics & numerical data, Young Adult, COVID-19 epidemiology, Health Knowledge, Attitudes, Practice, Pandemics, SARS-CoV-2, Students, Medical psychology
- Abstract
Background: As the disease caused by the novel coronavirus has spread globally, there has been significant economic instability in the healthcare systems. This reality was especially accentuated in Ecuador where, the shortage of healthcare workers combined with cultural and macroeconomic factors has led Ecuador to face the most aggressive outbreak in Latin America. In this context, the participation of final-year medical students on the front line is indispensable. Appropriate training on COVID-19 is an urgent requirement that universities and health systems must guarantee. We aimed to describe the knowledge, attitudes, and practices of Ecuadorian final-year medical students that could potentially guide the design of better medical education curricula regarding COVID-19., Methods: This was a cross-sectional 33-item online survey conducted between April 6 to April 2020 assessing the knowledge, attitudes, and practices toward the diagnosis, treatment, prevention, and prognosis toward COVID-19 in Ecuadorian final-year medical students. It was sent by email, Facebook, and WhatsApp., Results: A total of 309 students responded to the survey. Out of which 88% of students scored high (≥ 70% correct) for knowledge of the disease. The majority of students were pessimistic about possible government actions, which is reflected in the negative attitude towards the control of COVID-19 and volunteering during the outbreak in Ecuador (77%, and 58% of the students, respectively). Moreover, 91% of students said they did not have adequate protective equipment. The latter finding was significantly associated with negative attitudes., Conclusions: Although a large number of students displayed negative attitudes, the non-depreciable percentage of students who were willing to volunteer and the coexisting high level of knowledge displayed by students, suggests that Ecuador has a capable upcoming workforce that could benefit from an opportunity to strengthen, improve and advance their training in preparation for COVID-19. Not having personal protective equipment was significantly associated to negative attitudes. Providing the necessary tools and creating a national curriculum may be one of the most effective ways to ensure all students are trained, whilst simultaneously focusing on the students' most pressing concerns. With this additional training, negative attitudes will improve and students will be better qualified.
- Published
- 2021
- Full Text
- View/download PDF
42. A high-throughput multiplexed microfluidic device for COVID-19 serology assays.
- Author
-
Rodriguez-Moncayo R, Cedillo-Alcantar DF, Guevara-Pantoja PE, Chavez-Pineda OG, Hernandez-Ortiz JA, Amador-Hernandez JU, Rojas-Velasco G, Sanchez-Muñoz F, Manzur-Sandoval D, Patino-Lopez LD, May-Arrioja DA, Posadas-Sanchez R, Vargas-Alarcon G, and Garcia-Cordero JL
- Subjects
- Area Under Curve, COVID-19 virology, Coronavirus Nucleocapsid Proteins immunology, Humans, Immunoassay instrumentation, Immunoglobulin G blood, Immunoglobulin G immunology, Immunoglobulin M blood, Immunoglobulin M immunology, Lab-On-A-Chip Devices, Longitudinal Studies, Phosphoproteins immunology, Protein Domains immunology, ROC Curve, SARS-CoV-2 isolation & purification, Sensitivity and Specificity, Spike Glycoprotein, Coronavirus chemistry, Spike Glycoprotein, Coronavirus immunology, Antibodies, Viral blood, COVID-19 diagnosis, Immunoassay methods, SARS-CoV-2 immunology
- Abstract
The applications of serology tests to the virus SARS-CoV-2 are diverse, ranging from diagnosing COVID-19, understanding the humoral response to this disease, and estimating its prevalence in a population, to modeling the course of the pandemic. COVID-19 serology assays will significantly benefit from sensitive and reliable technologies that can process dozens of samples in parallel, thus reducing costs and time; however, they will also benefit from biosensors that can assess antibody reactivities to multiple SARS-CoV-2 antigens. Here, we report a high-throughput microfluidic device that can assess antibody reactivities against four SARS-CoV-2 antigens from up to 50 serum samples in parallel. This semi-automatic platform measures IgG and IgM levels against four SARS-CoV-2 proteins: the spike protein (S), the S1 subunit (S1), the receptor-binding domain (RBD), and the nucleocapsid (N). After assay optimization, we evaluated sera from infected individuals with COVID-19 and a cohort of archival samples from 2018. The assay achieved a sensitivity of 95% and a specificity of 91%. Nonetheless, both parameters increased to 100% when evaluating sera from individuals in the third week after symptom onset. To further assess our platform's utility, we monitored the antibody titers from 5 COVID-19 patients over a time course of several weeks. Our platform can aid in global efforts to control and understand COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
43. Use of pulmonary ultrasound to predict in-hospital mortality in patients with COVID-19 infection.
- Author
-
Manzur-Sandoval D, García-Cruz E, Gopar-Nieto R, Araiza-Garaygordobil D, Maza AG, Ramírez-Lara E, Zebadua-Torres R, Barajas-Campos RL, Rascón-Sabido R, Mendoza-Copa G, Chango-Criollo EI, Ramírez-Galindo G, and Rojas-Velasco G
- Subjects
- Aged, COVID-19 mortality, Critical Care, Female, Hospitalization, Humans, Male, Middle Aged, Point-of-Care Testing, Respiration, Artificial statistics & numerical data, COVID-19 complications, Hospital Mortality, Intensive Care Units, Lung diagnostic imaging, Ultrasonography
- Abstract
Introduction: Lung ultrasound (LUS) implementation in patients with COVID-19 can help to establish the degree of pulmonary involvement, evaluate treatment response and estimate in-hospital outcome., Objective: To evaluate the application of a LUS protocol in patients with COVID-19 infection to predict in-hospital mortality., Methods: The study was carried out from April 1 to August 1, 2020 in patients with COVID-19 infection admitted to the Intensive Care Unit. Lung evaluation was carried out by physicians trained in critical care ultrasonography., Results: Most patients were males, median age was 56 years, and 59 % required mechanical ventilation. In-hospital mortality was 39.4 %, and in those with a LUS score ≥ 19, mortality was higher (50 %). The multiple logistic regression model showed that a LUS score ≥ 19 was significantly associated with mortality (hazard ratio = 2.55, p = 0.01)., Conclusions: LUS is a safe and fast clinical tool that can be applied at bedside in patients with COVID-19 infection to establish the degree of parenchymal involvement and predict mortality., (Copyright: © 2021 Permanyer.)
- Published
- 2021
- Full Text
- View/download PDF
44. Woman with cough and shortness of breath.
- Author
-
González Ruiz FJ, Lazcano Díaz EA, López Reyes JC, Rojas Velasco G, Baranda Tovar FM, and Bucio Reta E
- Published
- 2020
- Full Text
- View/download PDF
45. Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity.
- Author
-
Torres-Machorro A, Anguiano-Álvarez VM, Grimaldo-Gómez FA, Rodríguez-Zanella H, Cortina de la Rosa E, Mora-Canela S, Lerma C, García-Cruz E, Ramos-Enriquez Á, Ramirez-Marroquin S, Izaguirre-Ávila R, and Rojas-Velasco G
- Subjects
- Autopsy, Critical Illness, Humans, Pandemics, Patients, Prospective Studies, SARS-CoV-2, COVID-19, Venous Thromboembolism, Venous Thrombosis drug therapy
- Published
- 2020
- Full Text
- View/download PDF
46. Critical care ultrasonography during COVID-19 pandemic: The ORACLE protocol.
- Author
-
García-Cruz E, Manzur-Sandoval D, Rascón-Sabido R, Gopar-Nieto R, Barajas-Campos RL, Jordán-Ríos A, Sierra-Lara Martínez D, Jiménez-Rodríguez GM, Murillo-Ochoa AL, Díaz-Méndez A, Lazcano-Díaz E, Araiza-Garaygordobil D, Cabello-López A, Melano-Carranza E, Bucio-Reta E, González-Ruiz FJ, Cota-Apodaca LA, Santos-Martínez LE, Fernández-de la Reguera G, Ramos-Enríquez Á, Rojas-Velasco G, Álvarez-Álvarez RJ, and Baranda-Tovar F
- Subjects
- Aged, Clinical Protocols, Cross-Sectional Studies, Feasibility Studies, Female, Heart diagnostic imaging, Heart physiopathology, Heart Diseases etiology, Heart Diseases physiopathology, Hemodynamics physiology, Humans, Lung diagnostic imaging, Lung physiopathology, Lung Diseases etiology, Lung Diseases physiopathology, Male, Middle Aged, Pandemics, Point-of-Care Systems, Ultrasonography instrumentation, COVID-19 complications, COVID-19 physiopathology, Critical Care methods, Heart Diseases diagnostic imaging, Lung Diseases diagnostic imaging, Ultrasonography methods
- Abstract
Background: Coronavirus disease 2019 (COVID-19) is characterized by severe lung involvement and hemodynamic alterations. Critical care ultrasonography is vital because it provides real time information for diagnosis and treatment. Suggested protocols for image acquisition and measurements have not yet been evaluated., Methods: This cross-sectional study was conducted at two centers from 1 April 2020 to 30 May 2020 in adult patients with confirmed COVID-19 infection admitted to the critical care unit. Cardiac and pulmonary evaluations were performed using the ORACLE protocol, specifically designed for this study, to ensure a structured process of image acquisition and limit staff exposure to the infection., Results: Eighty-two consecutively admitted patients were evaluated. Most of the patients were males, with a median age of 56 years, and the most frequent comorbidities were hypertension and type 2 diabetes, and 25% of the patients had severe acute respiratory distress syndrome. The most frequent ultrasonographic findings were elevated pulmonary artery systolic pressure (69.5%), E/e' ratio > 14 (29.3%), and right ventricular dilatation (28%) and dysfunction (26.8%). A high rate of fluid responsiveness (82.9%) was observed. The median score (19 points) on pulmonary ultrasound did not reveal any variation between the groups. Elevated pulmonary artery systolic pressure was associated with higher in-hospital mortality., Conclusion: The ORACLE protocol was a feasible, rapid, and safe bedside tool for hemodynamic and respiratory evaluation of patients with COVID-19. Further studies should be performed on the alteration in pulmonary hemodynamics and right ventricular function and its relationship with outcomes., (© 2020 Wiley Periodicals LLC.)
- Published
- 2020
- Full Text
- View/download PDF
47. Transthoracic echocardiography during prone position ventilation: Lessons from the COVID-19 pandemic.
- Author
-
García-Cruz E, Manzur-Sandoval D, Gopar-Nieto R, Murillo-Ochoa AL, Bejarano-Alva G, Rojas-Velasco G, Álvarez-Álvarez RJ, and Baranda-Tovar F
- Abstract
Objective: The current coronavirus disease 2019 (COVID-19 outbreak) demands an increased need for hospitalizations in emergency departments (EDs) and critical care units. Owing to refractory hypoxemia, prone position ventilation has been used more frequently and patients will need repeated hemodynamic assessments. Our main objective was to show the feasibility of obtaining images to measure multiple parameters with transthoracic echocardiography during the prone position ventilation., Methods: We enrolled 15 consecutive mechanically ventilated patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that required prone position ventilation as a rescue maneuver for refractory hypoxemia. The studies were performed by 2 operators with training in critical care echocardiography. Measurements were done outside the patient's room and the analysis of the images was performed by 3 cardiologists with training in echocardiography., Results: Adequate image acquisition of the left ventricle was possible in all cases; we were not able to visualize the right ventricular free wall only in 1 patient. The mean tricuspid annular plane systolic excursion was 17.8 mm, tricuspid peak systolic S wave tissue Doppler velocity 11.5 cm/s, and the right ventricular basal diameter 36.6 mm; left ventricle qualitative function was reduced in 6 patients; pericardial effusion or valvular abnormalities were not observed., Conclusion: We showed that echocardiographic images can be obtained to measure multiple parameters during the prone position ventilation. This technique has special value in situations where there is sudden hemodynamic deterioration and it is not possible to return the patient in the supine position., Competing Interests: The authors declare that there are no conflicts of interest to disclose., (© 2020 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of the American College of Emergency Physicians.)
- Published
- 2020
- Full Text
- View/download PDF
48. Hemodynamic profiles related to circulatory shock in cardiac care units.
- Author
-
Gonzalez-Hermosillo JA, Palma-Carbajal R, Rojas-Velasco G, Cabrera-Jardines R, Gonzalez-Galvan LM, Manzur-Sandoval D, Jiménez-Rodriguez GM, and Ortiz-Solis WA
- Subjects
- Echocardiography methods, Humans, Shock therapy, Shock, Cardiogenic physiopathology, Shock, Cardiogenic therapy, Ultrasonography methods, Coronary Care Units, Hemodynamics physiology, Shock physiopathology
- Abstract
One-third of the population in intensive care units is in a state of circulatory shock, whose rapid recognition and mechanism differentiation are of great importance. The clinical context and physical examination are of great value, but in complex situations as in cardiac care units, it is mandatory the use of advanced hemodynamic monitorization devices, both to determine the main mechanism of shock, as to decide management and guide response to treatment, these devices include pulmonary flotation catheter as the gold standard, as well as more recent techniques including echocardiography and pulmonary ultrasound, among others. This article emphasizes the different shock mechanisms observed in the cardiac care units, with a proposal for approach and treatment., (Copyright: © 2020 Permanyer.)
- Published
- 2020
- Full Text
- View/download PDF
49. Atrial fibrillation in cardiac surgery.
- Author
-
Baeza-Herrera LA, Rojas-Velasco G, Márquez-Murillo MF, Portillo-Romero ADR, Medina-Paz L, Álvarez-Álvarez R, Ramos-Enríquez Á, and Baranda-Tovar FM
- Subjects
- Atrial Fibrillation epidemiology, Atrial Fibrillation therapy, Cardiac Surgical Procedures adverse effects, Electric Countershock methods, Humans, Risk Factors, Atrial Fibrillation etiology, Cardiac Surgical Procedures methods, Postoperative Complications epidemiology
- Abstract
Atrial fibrillation is the most frequent arrhythmia in the postoperative period of cardiac surgery. It is associated with heart failure, renal insufficiency, systemic embolism and increase in days of in-hospital and mortality. Atrial fibrillation in the postoperative period of cardiac surgery (FAPCC) usually appears in the first 48 h after surgery. The main mechanisms involved in the appearance and maintenance of FAPCC are the increase in sympathetic tone and the inflammatory response. The associated risk factors are advanced age, chronic obstructive pulmonary disease, chronic kidney disease, valve surgery, fraction of ejection of the left ventricle < 40% and the withdrawal of beta-blocker drugs. There are instruments that have been shown to predict the appearance of FAPCC. Prophylactic treatment with beta-blockers and amiodarone, is associated with a decrease in the appearance of FAPCC. Given its transient nature, it is suggested that the initial treatment of FAPCC be the heart rate control and only if the treatment does not achieve a return to sinus rhythm, the use of electrical cardioversion is suggested. It is unknown what should be the long-term follow-up and complications beyond this period are little known. FAPCC is not a benign or isolated arrhythmia in patients undergoing cardiac surgery, so the identification of risk factors, their prevention, and follow-up in the outpatient setting, should be part of the units dedicated to the care and care of these patients., (Copyright: © 2019 Permanyer.)
- Published
- 2019
- Full Text
- View/download PDF
50. Lung ultrasound in cardiology: realities and promises.
- Author
-
Gopar-Nieto R, Alanís-Estrada GP, Ronquillo-Ramírez DE, Vargas-Estrada JL, Arias-Mendoza A, Rojas-Velasco G, and Araiza-Garaygordobil D
- Subjects
- Critical Illness, Dyspnea diagnostic imaging, Heart Failure diagnostic imaging, Humans, Pulmonary Edema diagnostic imaging, Dyspnea etiology, Lung diagnostic imaging, Ultrasonography methods
- Abstract
Lung ultrasound is an easily available, reproducible examination tool, both in ambulatory and critically-ill patients, which is used to evaluate congestion status and to differentiate the etiology of dyspnea. In this review, we explain lung ultrasound technique, acquisition protocols and their interpretation, as well as the evidence that shows its effectiveness among stable and critically-ill patients. Lung ultrasound should be used as an add-on to traditional physical examination in order to give an accurate diagnosis and a rapid treatment to patients with pulmonary congestion., (Copyright: © 2019 Permanyer.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.